期刊文献+

Ad5介导mGM-CSF基因修饰A549细胞肿瘤疫苗的实验研究

Experimental Study on Ad5-Mediated mGM-CSF Gene Modified A549 Tumor Cell Vacccines
下载PDF
导出
摘要 【目的】探讨Ad5介导mGM-CSF基因修饰A549细胞肿瘤疫苗在模型小鼠的有效性。【方法】Ad5/mGM-CSF感染体外培养的A549细胞(MOI=20),24 h后将A549细按照7×106细胞/0.1 mL/支分装冻存,20000rad照射灭活,溶化后直接用于注射;4周龄雄性C57小鼠,左腋下皮下接种A549细胞3 d后开始在右腋下皮下接种主动免疫制剂1支,以单纯经过照射的同等剂量的A549细胞为对照,每周1次,连续5周,每3 d记录肿瘤发生率、测量瘤体积。【结果】Ad5/mGM-CSF能有效的感染A549细胞,其表达量为524ng/106cell/24 h;肿瘤细胞+GM-CSF主动免疫疗法能够有效抑制皮下接种肿瘤的发生和增长。【结论】Ad5介导mGM-CSF基因修饰A549细胞肿瘤疫苗能有效的抑制A549细胞的增殖,为临床应用打下一定的基础。 [Objective] To explore the availability of Ad5-mediated mGM-CSF gene modified A549 tumor cell vaccines on mouse model. [Methods] Ad5/mGM-CSF was infected into A549 cells in vitro(MOI= 20). Infected A549 cells were subpackaged and cryopreserved according to 7 × 10^6 cells/0, lmL/ramus after 24 hours later, and inactivated with 20000rad irradiating, and used directly for injection after colliquated. 4-week-old male C57 mouse was inoculated A549 cells subcutaneouly at left armpit, and inoculated one active immunity preparation subcutaneouly at right armpit after 3 days later, as compared with A549 cells exposed to isodose per week and continuously for 5 weeks. Tumorigenesis rate and tumour volume were noted. [Results] Ad5/ mGM-CSF was effectively infected into A549 cells with expression by 524ng/10^6cell/24 hours. Tumor cells plus GM-CSF active immunotherapy effectively suppressed the generation and growth of hypodermically inoculated tumor. [Conclusion] Ad5-mediated mGM-CSF gene modified A549 tumor cell vaccines could effectively suppress proliferation of A549 cells.
出处 《医学临床研究》 CAS 2007年第10期1734-1736,共3页 Journal of Clinical Research
关键词 癌症疫苗 粒细胞巨噬细胞集落刺激因子 基因 cancer vaccines granulocyte macrophage colony-stimulating factors genes
  • 相关文献

参考文献10

  • 1Catros2Quemener V,Bouet F,Genetet N.Antiturrlor immunity and cellular cancer therap ies[J].Med Sci(Paris),2003,19(1):43-53.
  • 2Restifo NP,Esquivel F,Kawakami Y,et al.Identiffcation of human cancers defident in antigen P rocessing[J].J Exp Med,1993,177(2):265-272.
  • 3Nencioni A,MullerMR,Grunebach F,et al.Dendritic cells transfected with tumor RNA for the induction of antitumor CTL in colorectal cancer[J].Cancer Gene Ther,2003,10(3):209-214.
  • 4Demir G,Klein HO,TuzunerN.Low dose daily rhGM2CSF app li2cation activates monocytes and dendritic cells in vivo[J].Leuk Res,2003,27(12):1105-1108.
  • 5Schwaab T,Tretter CP,Gibson JJ,et al.Immunological effects of granulocyte-macrophage colony-stimulating factor and autologous tumor vaccine in patients with renal cell carcinomal[J].J Urol,2004,171(3):1036-1042.
  • 6Hang DZ,Lomazow W,Joy Somberg C,et al.Granulocytemacrophage colony stimulating factor:an adjuvant for cancer vaccines[J].Hemotology,2004,9(3):207-215.
  • 7Atkins MB,Kunkel L,Sznol M,et al.Cyclophosphamide,doxorubicin,and paclitaxel enhance the antitumor immune response of granulocyte/macrophage-colony stimulating factor-secreting whole-cell.vaccines in her-2/neu tolerized mice[J].Cancer Res,2001,61:3689-3697.
  • 8Nemunaitis J.Sterman D,Hege K,et al.Granulocyte-macrophage colony-stimulating factor gene-modified autologous tumor vaccines in non-small-cell lung cancer[J].J Natl Cancer Ins,2004;96(4):326-331.
  • 9Nagai E,Ogawa T,Kielian T,et al.Irradiatedtumor cells adenovirally engineered to secrete granulocyte/macrophagecolony-stimulating factor establish antitumor immunity andeliminate pre-existing tumors in syngeneic mice[J].Cancer Immunol Immunother,1998,47(2):72-80.
  • 10ArcaMJ,Krauss JC,Strome SE,et al.Diverse manifestations of tumorigenicity and immunogenicity displayed by the poorly immunogenic B16-BL6 melanoma traneducedwith cytokine genes[J].Cancer Immunol Immunother,1996,42(4):237-245.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部